# TRACEABILITY STAGE 38 ORCHESTRATION REVIEW

Date: 2026-06-02
Scope: quick traceability and quality review of the backend orchestration skeleton

## Verdict
Pass.

Stage 38 keeps the orchestration layer in the correct role: a runtime skeleton that validates plans, emits stubbed orchestration responses, and preserves the incoming trace_id without creating or mutating case-level trace/evidence records. That is the right boundary for this phase.

## Findings

### 1) Is the no-schema orchestration audit compatible with the Stage 37 boundary?
Yes.

The new `POST /api/v1/orchestrations/validate-plan` and `POST /api/v1/orchestrations/run` endpoints behave as a response/log-level orchestration audit skeleton. They do not create orchestration tables, and they do not write case-level `trace_events`, `evidence_nodes`, or `evidence_edges`.

That is consistent with the Stage 37 contract.

### 2) trace_id passthrough
Correct.

The orchestration layer requires an incoming `trace_id` and forwards it unchanged. It does not generate a new trace_id or replace the caller-provided one.

### 3) Are orchestration_run_id / step_id / agent_invocation_id good future audit key candidates?
Yes.

They are suitable skeleton identifiers for future persistence because they already form a stable hierarchy:
- `orchestration_run_id`
- `step_id`
- `agent_invocation_id`

That is a solid shape for eventual storage if the team later decides to persist orchestration audit tables.

### 4) no_silent_fallback and unavailability semantics
Good.

Unsupported agent, unsupported task, unsupported modality, agent_unavailable, and timeout conditions are explicit. The contract does not hide substitution or fabricate success. That is the right behavior for a governed skeleton.

### 5) Parallel skeleton conflict expression
Mostly acceptable, with a stub warning.

The current stub conflict object is fine as a placeholder because it is clearly marked as stubbed and the body explains that semantic conflict analysis is not yet implemented. That said, this should remain clearly labeled in UI or caller-facing docs so it is not mistaken for a clinically validated conflict.

### 6) Not writing case trace/evidence
Still correct.

Stage 38 should not yet write case trace/evidence because the orchestration layer is still proving request/response shape, capability validation, and stubbed parallel execution. Premature trace promotion would blur the boundary that Stage 37 just established.

### 7) What should eventually enter case trace/evidence?
Only clinically meaningful outputs should be promoted there, especially:
- final recommendation
- key agent outputs that materially influenced the recommendation
- conflict summary when it changes or explains the recommendation
- doctor confirmation requirements
- doctor-confirmed overrides or rejections

Routine orchestration bookkeeping should stay in orchestration audit.

### 8) Should Stage 39 continue no-schema or start migration design?
Recommend starting migration design, but not application.

Stage 38 has validated the skeleton shape well enough that Stage 39 can begin designing an orchestration audit migration contract. The next step should be schema design and field mapping only, not Alembic application.

### 9) Runtime stub and stub conflict risk
Low, as long as the stub labeling remains explicit.

`runtime_stub:true` is doing useful safety work. The only residual risk is human misreading, especially if the response is shown without a clear demo/stub label. The code itself is not pretending to be production inference.

## Must-fix items
- None for the current Stage 38 review scope.

## Recommendation
- Suitable for Git checkpoint.
- Stage 39 should begin orchestration audit migration design, not migration application.
- Keep orchestration audit separate from case trace/evidence.

## Constraints confirmed
- No schema changes.
- No Alembic execution.
- No Nginx enablement.
- No real-model connection.
- No training.
- No `.pth/.pt/.onnx/.ckpt/.safetensors` operations.
